Last updated 2026-07-26
- Raised $55M Series C led by OrbiMed, Mar 2021
- Raised $22M C Round Extension led by Sands Capital, Dec 2021
- Raised $5.4M Series A led by OrbiMed, May 2014
Total raised
$88.3M
Last: Undisclosed Round 2022-01
Stage
Series C
Founded
2008
Headcount
72
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
Nucleix is a liquid biopsy company that aims to revolutionize cancer treatment through earlier disease detection, when intervention can have the greatest impact for patients. The company leverages PCR-based epigenetics and methylation-based identification for early-stage and recurring cancer detection. Its non-invasive EpiCheck® platform delivers highly accurate and sensitive results. Nucleix operates globally with offices in San Diego, United States, and Rehovot, Israel.
Funding history · 5 rounds · $88.3M total
2021-12
C Round Extension
$22.0M
★ Sands CapitalOrbiMedZohar Zisapel (Late)RA Capital Management
2021-03
C Round
$55.0M
★ OrbiMed★ BlackRock★ LYFE Capital★ Gefen Capital★ DSC Investment★ Lilly Asia Ventures★ Zohar Zisapel (Late)★ Aurum Ventures M.K.IMILFAMRA Capital Management
2018-06
Grant
$2.9M
2016-04
B Round
$3.0M
★ Zohar Zisapel (Late)★ Aurum Ventures M.K.I
2014-05
A Round
$5.4M
★ OrbiMed★ Zohar Zisapel (Late)
Headcount over time
From 22 (2018-07) to 72 (2026-03) · +50 (+227%) · 50 points · source: Finder history + radar grounding
Q&A
- What is Nucleix's primary focus?
- Nucleix is a liquid biopsy company dedicated to revolutionizing cancer treatment through earlier disease detection, utilizing PCR-based epigenetics and methylation-based identification.
- What is the total amount of funding Nucleix has raised to date?
- Nucleix has raised a total of $143 million in funding.
- Which product of Nucleix received FDA 510(k) Clearance recently?
- In May 2023, Nucleix's Bladder EpiCheck® received FDA 510(k) Clearance for monitoring non-muscle invasive bladder cancer (NMIBC) recurrence.
- What is the current employee count for Nucleix?
- Nucleix has 72 employees, falling within the 51-200 employee bucket.
- What is the status of Nucleix's Lung EpiCheck® test?
- Nucleix is advancing its Lung EpiCheck® test towards commercialization for high-risk individuals, and data on its EpiCheck® Lung Cancer Atlas was premiered in April 2023 at the American Association for Cancer Research Annual Meeting.
- What accreditations and certifications did Nucleix receive for its San Diego laboratory?
- In October 2022, Nucleix received CAP Accreditation and CLIA Certification for its San Diego Clinical Laboratory.
- Which clinical guidelines include Nucleix's Bladder EpiCheck®?
- In March 2022, Bladder EpiCheck® was included in the 2022.
Team · 2
Danny Frumkin
Founder · Co-founder
Adam Wasserstrom
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
Artificial IntelligenceMachine LearningBiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesHealthcareProvidersPatientsLaboratories
Business model
B2B
Highlights
1 PatentsVerified
Tags
bioinformaticsbiopsymedical-technologiesnon-invasivedetectiondiagnosticsgenomicscancerbiomarkersblood-testlaboratoriesearly-detectionclinicshospitalscancer-therapybig-data
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | nucleix.com |
|---|---|
| linkedin.com/company/1670969 | |
| facebook.com/Nucleix-100608201471224 | |
| YouTube | youtube.com/channel/UCZ-2RIVy9QbNCsko6S3L1Kw |
| Wikidata | wikidata.org/wiki/Q50038748 |
Identifiers & details
| Legal name | NUCLEIX LTD |
|---|---|
| Founded | 2008 |
| Employees (exact) | 72 |
| Offices | San Diego; Modi'in-Maccabim-Re'ut |
| Wikidata QID | Q50038748 |
Radar intelligence
Patents
| EPO | 31 |
|---|
Publications (Crossref)
| Works | 3 |
|---|
Web history (Wayback)
| Domain | nucleix.com |
|---|
Wikidata
| QID | Q50038748 |
|---|
Certificate / subdomain footprint
| Subdomains | 24 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514134568 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2008-05-07 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 2 |
| Registry events | 8 — charge (2), annual_report (1), people (3), other (1), shares_capital (1) |
| Registered address | פקריס 3 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-28 | רישום שעבוד |
| 2026-06-28 | רישום שעבוד |
| 2026-03-28 | דו~ח שנתי |
| 2026-07-21 | עדכון דירקטורים-הסרת דירקטור |
| 2026-07-21 | עדכון דירקטורים-הוספת דירקטור |
| 2026-07-19 | שינוי בתקנון |
| 2026-02-12 | עדכון דירקטורים-עדכון מנהלים |
| 2025-11-04 | הקצאת מניות |